Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Advanced Materials, 2024

DOI: 10.1002/adma.202307679

Links

Tools

Export citation

Search in Google Scholar

Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractTriggering lysosome‐regulated immunogenic cell death (ICD, e.g., pyroptosis and necroptosis) with nanomedicines is an emerging approach for turning an “immune‐cold” tumor “hot”— a key challenge faced by cancer immunotherapies. Proton sponge such as high‐molecular‐weight branched polyethylenimine (PEI) is excellent at rupturing lysosomes, but its therapeutic application is hindered by uncontrollable toxicity due to fixed charge density and poor understanding of resulted cell death mechanism. Here, a series of proton sponge nano‐assemblies (PSNAs) with self‐assembly controllable surface charge density and cell cytotoxicity were created. Such PSNAs were constructed via low‐molecular‐weight branched PEI covalently bound to self‐assembling peptides carrying tetraphenylethene pyridinium (PyTPE, an aggregation‐induced emission based luminogen). Assembly of PEI assisted by the self‐assembling peptide‐PyTPE led to enhanced surface positive charges and cell cytotoxicity of PSNA. The self‐assembly tendency of PSNAs was further optimized by tuning hydrophilic and hydrophobic components within the peptide, thus resulting in the PSNA with the highest fluorescence, positive surface charge density, cell uptake, and cancer cell cytotoxicity. Systematic cell death mechanistic studies revealed that the lysosome rupturing‐regulated pyroptosis and necroptosis are at least two causes of the cell death. Tumor cells undergoing PSNA‐triggered ICD activated immune cells, suggesting the great potential of PSNAs to trigger anticancer immunity.This article is protected by copyright. All rights reserved